Skip to main content
Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences 1/2008

Open Access 01.01.2008

Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors

verfasst von: Masaru Miyazaki, Tadahiro Takada, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Junji Furuse, Hiroya Saito, Toshio Tsuyuguchi, Kazuo Chijiiwa, Fumio Kimura, Hideyuki Yoshitomi, Satoshi Nozawa, Masahiro Yoshida, Keita Wada, Hodaka Amano, Fumihiko Miura

Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Curative resection is the only treatment for biliary tract cancer that achieves long-term survival. However, patients with advanced biliary tract cancer have only a limited prognosis even after radical surgical resection. Thus, to improve the longterm results, the early detection of biliary tract cancer and subsequent cure seem to be essential. The purpose of this study was to review the literature concerning the risk factors for cancerous and precancerous lesions of the biliary tract, and prophylactic surgery for these factors. It has been reported that pancreaticobiliary maljunction (PBM) with bile duct dilatation is a risk factor for gallbladder cancer and bile duct cancer, while PBM without bile duct dilatation is a risk factor for gallbladder cancer. Thus, in the former group, a prophylactic excision of the common bile duct and gallbladder should be recommended, while in the later group, a prophylactic cholecystectomy without bile duct resection may be the appropriate surgical procedure. It has also been reported that primary sclerosing cholangitis (PSC) is a risk factor for cholangiocarcinoma. Patients with PSC often develop advanced cholangiocarcinoma with a poor prognosis. In patients with PSC, therefore, strict follow-up should be recommended. Adenoma and dysplasia have been regarded as precancerous lesions of gallbladder cancer. A polypoid lesion of the gallbladder that is sessile, has a diameter greater than 10 mm, and /or grows rapidly, is highly likely to be cancerous and should be resected. Although gallstones seem to be closely associated with gallbladder cancer, there is no evidence of a direct causal relationship between gallstones and gallbladder cancer. Thus, a cholecystectomy is not advised for asymptomatic cholecystolithiasis. Controversy remains as to whether adenomyomatosis of the gallbladder and porcelain gallbladder are associated with gallbladder cancer. With respect to ampullary carcinoma, adenoma of the ampulla is considered to be a precancerous lesion. This article discusses the risk factors for cancerous and precancerous lesions of the biliary tract and prophylactic treatment for these factors.
Literatur
1.
Zurück zum Zitat Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol 2000;95:1402–10.CrossRefPubMed Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol 2000;95:1402–10.CrossRefPubMed
2.
Zurück zum Zitat Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002;93:842–7.PubMed Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002;93:842–7.PubMed
3.
Zurück zum Zitat Tashiro S, Imaizumi T, Ohkawa H, Okada A, Katoh T, Kawaharada Y, et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg 2003;10:345–51.CrossRefPubMed Tashiro S, Imaizumi T, Ohkawa H, Okada A, Katoh T, Kawaharada Y, et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg 2003;10:345–51.CrossRefPubMed
4.
Zurück zum Zitat Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21–5.CrossRefPubMed Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21–5.CrossRefPubMed
5.
Zurück zum Zitat Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991;11:26–30.CrossRefPubMed Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991;11:26–30.CrossRefPubMed
6.
Zurück zum Zitat Callea F, Sergi C, Fabbretti G, Brisigotti M, Cozzutto C, Medicina D. Precancerous lesions of the biliary tree. J Surg Oncol Suppl 1993;3:131–3.CrossRefPubMed Callea F, Sergi C, Fabbretti G, Brisigotti M, Cozzutto C, Medicina D. Precancerous lesions of the biliary tree. J Surg Oncol Suppl 1993;3:131–3.CrossRefPubMed
7.
Zurück zum Zitat Franco J, Saeian K. Biliary tract inflammatory disorders. primary sclerosing cholangitis and primary biliary cirrhosis. Curr Gastroenterol Rep 1999;1:95–101.CrossRefPubMed Franco J, Saeian K. Biliary tract inflammatory disorders. primary sclerosing cholangitis and primary biliary cirrhosis. Curr Gastroenterol Rep 1999;1:95–101.CrossRefPubMed
8.
Zurück zum Zitat Hsing AW, Bai Y, Andreotti G, Rashid A, Deng J, Chen J, et al. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer 2007;121:832–8.CrossRefPubMed Hsing AW, Bai Y, Andreotti G, Rashid A, Deng J, Chen J, et al. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer 2007;121:832–8.CrossRefPubMed
9.
Zurück zum Zitat Nabatame N, Shirai Y, Nishimura A, Yokoyama N, Wakai T, Hatakeyama K. High risk of gallbladder carcinoma in elderly patients with segmental adenomyomatosis of the gallbladder. J Exp Clin Cancer Res 2004;23:593–8.PubMed Nabatame N, Shirai Y, Nishimura A, Yokoyama N, Wakai T, Hatakeyama K. High risk of gallbladder carcinoma in elderly patients with segmental adenomyomatosis of the gallbladder. J Exp Clin Cancer Res 2004;23:593–8.PubMed
10.
Zurück zum Zitat Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:2–6.CrossRefPubMed Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:2–6.CrossRefPubMed
11.
Zurück zum Zitat Su WC, Shiesh SC, Liu HS, Chen CY, Chow NH, Lin XZ. Expression of oncogene products HER2/Neu and Ras and fibrosisrelated growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci 2001;46:1387–92.CrossRefPubMed Su WC, Shiesh SC, Liu HS, Chen CY, Chow NH, Lin XZ. Expression of oncogene products HER2/Neu and Ras and fibrosisrelated growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci 2001;46:1387–92.CrossRefPubMed
12.
Zurück zum Zitat Matsumoto Y, Fujii H, Itakura J, Matsuda M, Yang Y, Nobukawa B, Suda K. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis. Langenbecks Arch Surg 2003;388:122–31.PubMed Matsumoto Y, Fujii H, Itakura J, Matsuda M, Yang Y, Nobukawa B, Suda K. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis. Langenbecks Arch Surg 2003;388:122–31.PubMed
13.
Zurück zum Zitat Tanaka K, Nishimura A, Yamada K, Ishibe R, Ishizaki N, Yoshimine M, et al. Cancer of the gallbladder associated with anomalous junction of the pancreatobiliary duct system without bile duct dilatation. Br J Surg. 1993;80:622–4.CrossRefPubMed Tanaka K, Nishimura A, Yamada K, Ishibe R, Ishizaki N, Yoshimine M, et al. Cancer of the gallbladder associated with anomalous junction of the pancreatobiliary duct system without bile duct dilatation. Br J Surg. 1993;80:622–4.CrossRefPubMed
14.
Zurück zum Zitat Kumar JR, Tewari M, Rai A, Sinha R, Mohapatra SC, Shukla HS. An objective assessment of demography of gallbladder cancer. J Surg Oncol. 2006;93:610–4.CrossRefPubMed Kumar JR, Tewari M, Rai A, Sinha R, Mohapatra SC, Shukla HS. An objective assessment of demography of gallbladder cancer. J Surg Oncol. 2006;93:610–4.CrossRefPubMed
15.
16.
Zurück zum Zitat David FR, William AG. Treatment of gallstones. Ann Intern Med 1993;119:606–19. David FR, William AG. Treatment of gallstones. Ann Intern Med 1993;119:606–19.
17.
Zurück zum Zitat Gracie WA, Ransohoff DF. The natural history of silent gallstones. N Engl J Med 1982;307:798–800.PubMedCrossRef Gracie WA, Ransohoff DF. The natural history of silent gallstones. N Engl J Med 1982;307:798–800.PubMedCrossRef
18.
Zurück zum Zitat Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 2001;129:699–703.CrossRefPubMed Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 2001;129:699–703.CrossRefPubMed
19.
Zurück zum Zitat Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gallbladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 2001;386:224–9.CrossRefPubMed Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gallbladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 2001;386:224–9.CrossRefPubMed
20.
Zurück zum Zitat Towfigh S, McFadden DW, Cortina GR, Thompson JE, Tompkins RK, Chandler C, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg 2001;67:7–10.PubMed Towfigh S, McFadden DW, Cortina GR, Thompson JE, Tompkins RK, Chandler C, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg 2001;67:7–10.PubMed
21.
Zurück zum Zitat Roa I, de Aretxabala X, Araya JC, Roa J. Preneoplastic lesions in gallbladder cancer. J Surg Oncol 2006;93:615–23.CrossRefPubMed Roa I, de Aretxabala X, Araya JC, Roa J. Preneoplastic lesions in gallbladder cancer. J Surg Oncol 2006;93:615–23.CrossRefPubMed
22.
Zurück zum Zitat Yamagiwa H. Mucosal dysplasia of gallbladder: isolated and adjacent lesions to carcinoma. Jpn J Cancer Res 1989;80:238–43.PubMed Yamagiwa H. Mucosal dysplasia of gallbladder: isolated and adjacent lesions to carcinoma. Jpn J Cancer Res 1989;80:238–43.PubMed
23.
Zurück zum Zitat Kubota K, Bandai Y, Noie T, Ishizaki Y, Teruya M, Makuuchi M. How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery 1995;117:481–7.CrossRefPubMed Kubota K, Bandai Y, Noie T, Ishizaki Y, Teruya M, Makuuchi M. How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery 1995;117:481–7.CrossRefPubMed
24.
Zurück zum Zitat Ishikawa O, Ohhigashi H, Imaoka S, Nakaizumi A, Kitamura T, Sasaki Y, et al. The difference in malignancy between pedunculated and sessile polypoid lesions of the gallbladder. Am J Gastroenterol 1989;84:1386–90.PubMed Ishikawa O, Ohhigashi H, Imaoka S, Nakaizumi A, Kitamura T, Sasaki Y, et al. The difference in malignancy between pedunculated and sessile polypoid lesions of the gallbladder. Am J Gastroenterol 1989;84:1386–90.PubMed
25.
Zurück zum Zitat Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gallbladder lesions: analysis in surgical and follow up series. Gut 2000;46:250–4.CrossRefPubMed Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gallbladder lesions: analysis in surgical and follow up series. Gut 2000;46:250–4.CrossRefPubMed
26.
Zurück zum Zitat Aldridge MC, Bismuth H. Gallbladder cancer: the polyp-cancer sequence. Br J Surg 1990;77:363–4.CrossRefPubMed Aldridge MC, Bismuth H. Gallbladder cancer: the polyp-cancer sequence. Br J Surg 1990;77:363–4.CrossRefPubMed
27.
Zurück zum Zitat Kimura W, Futakawa N, Zhao B. Neoplastic diseases of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004;11:223–31.CrossRefPubMed Kimura W, Futakawa N, Zhao B. Neoplastic diseases of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004;11:223–31.CrossRefPubMed
28.
Zurück zum Zitat Sekido H, Shomada H, Morita T, Matsuo K, Kunihoro O, Miura Y, et al. Indications for surgery and optimal extent of resection of the bile duct: surgical treatment for pancreaticobiliary maljunction. In: Koyanagi K, Aoki T, editors. Pancreaticobiliary maljunction. Tokyo: Igaku Tosho Shuppan; 2002. p. 303–10. Sekido H, Shomada H, Morita T, Matsuo K, Kunihoro O, Miura Y, et al. Indications for surgery and optimal extent of resection of the bile duct: surgical treatment for pancreaticobiliary maljunction. In: Koyanagi K, Aoki T, editors. Pancreaticobiliary maljunction. Tokyo: Igaku Tosho Shuppan; 2002. p. 303–10.
29.
Zurück zum Zitat Kobayashi S, Asano T, Yamasaki M, Kenmochi T, Saigo K, Ochiai T. Prophylactic excision of the gallbladder and bile duct for patients with pancreaticobiliary maljunction. Arch Surg. 2001;136:759–63.CrossRefPubMed Kobayashi S, Asano T, Yamasaki M, Kenmochi T, Saigo K, Ochiai T. Prophylactic excision of the gallbladder and bile duct for patients with pancreaticobiliary maljunction. Arch Surg. 2001;136:759–63.CrossRefPubMed
30.
Zurück zum Zitat Ohuchida J, Chijiiwa K, Hiyoshi M, Kobayashi K, Konomi H, Tanaka M. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation Arch Surg. 2006;141:1066–70.CrossRefPubMed Ohuchida J, Chijiiwa K, Hiyoshi M, Kobayashi K, Konomi H, Tanaka M. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation Arch Surg. 2006;141:1066–70.CrossRefPubMed
31.
Zurück zum Zitat Masuhara S, Kasuya K, Aoki T, Yoshimatsu A, Tsuchida A, Koyanagi Y. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 2000;7:198–205.CrossRefPubMed Masuhara S, Kasuya K, Aoki T, Yoshimatsu A, Tsuchida A, Koyanagi Y. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 2000;7:198–205.CrossRefPubMed
32.
Zurück zum Zitat Ando H, Ito T, Nagaya M, Watanabe Y, Seo T, Kaneko K. Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg 1995;30:1658–62.CrossRefPubMed Ando H, Ito T, Nagaya M, Watanabe Y, Seo T, Kaneko K. Pancreaticobiliary maljunction without choledochal cysts in infants and children: clinical features and surgical therapy. J Pediatr Surg 1995;30:1658–62.CrossRefPubMed
33.
Zurück zum Zitat Matsubara T, Zhi LZ, Miura H, Sakurai Y, Imazu H, Imai H, et al. High carcinogenic potential of biliary epithelium in patients with pancreaticobiliary maljunction. In: Koyanagi K, Aoki T, editors. Pancreaticobiliary maljunction. Tokyo: Igaku Tosho Shuppan; 2002. p. 285–94. Matsubara T, Zhi LZ, Miura H, Sakurai Y, Imazu H, Imai H, et al. High carcinogenic potential of biliary epithelium in patients with pancreaticobiliary maljunction. In: Koyanagi K, Aoki T, editors. Pancreaticobiliary maljunction. Tokyo: Igaku Tosho Shuppan; 2002. p. 285–94.
34.
Zurück zum Zitat Maringhini A, Moreau JA, Melton LJ 3rd, Hench VS, Zinsmeister AR, DiMagno EP. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med 1987;107:30–5.PubMed Maringhini A, Moreau JA, Melton LJ 3rd, Hench VS, Zinsmeister AR, DiMagno EP. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med 1987;107:30–5.PubMed
35.
Zurück zum Zitat Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995;21:655–60.CrossRefPubMed Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995;21:655–60.CrossRefPubMed
36.
Zurück zum Zitat Chijiiwa K, Tanaka M. Polypoid lesion of the gallbladder: indications of carcinoma and outcome after surgery for malignant polypoid lesion. Int Surg 1994;79:106–9.PubMed Chijiiwa K, Tanaka M. Polypoid lesion of the gallbladder: indications of carcinoma and outcome after surgery for malignant polypoid lesion. Int Surg 1994;79:106–9.PubMed
37.
Zurück zum Zitat Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol 2002;16:187–94.PubMed Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol 2002;16:187–94.PubMed
38.
Zurück zum Zitat Mainprize KS, Gould SWT, Gilbert JM. Surgical management of polypoid lesions of the gallbladder. Br J Surg 2000;87:414–7.CrossRefPubMed Mainprize KS, Gould SWT, Gilbert JM. Surgical management of polypoid lesions of the gallbladder. Br J Surg 2000;87:414–7.CrossRefPubMed
39.
Zurück zum Zitat Akatsu T, Aiura K, Shimazu M, Ueda M, Wakabayashi G, Tanabe M, et al. Can endoscopic sonography differentiate nonneoplastic from neoplastic gallbladder polyps? Dig Dis Sci 2006;51:416–21.CrossRefPubMed Akatsu T, Aiura K, Shimazu M, Ueda M, Wakabayashi G, Tanabe M, et al. Can endoscopic sonography differentiate nonneoplastic from neoplastic gallbladder polyps? Dig Dis Sci 2006;51:416–21.CrossRefPubMed
Metadaten
Titel
Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors
verfasst von
Masaru Miyazaki
Tadahiro Takada
Shuichi Miyakawa
Kazuhiro Tsukada
Masato Nagino
Satoshi Kondo
Junji Furuse
Hiroya Saito
Toshio Tsuyuguchi
Kazuo Chijiiwa
Fumio Kimura
Hideyuki Yoshitomi
Satoshi Nozawa
Masahiro Yoshida
Keita Wada
Hodaka Amano
Fumihiko Miura
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
Journal of Hepato-Biliary-Pancreatic Sciences / Ausgabe 1/2008
Print ISSN: 1868-6974
Elektronische ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-007-1276-8

Weitere Artikel der Ausgabe 1/2008

Journal of Hepato-Biliary-Pancreatic Sciences 1/2008 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.